Technology ID
TT-0113
Description
The SGC biologic is a groundbreaking innovation in refractory wound care, utilizing patented protein-based regenerative technology. Clinically validated in top-tier 3A hospitals, it has demonstrated exceptional efficacy in healing stubborn and hard-to-treat wounds. By accelerating the healing process, it significantly reduces treatment time and associated costs, providing an efficient and cost-effective solution for patients and healthcare providers.
Content
Personalized Effectiveness: Treatments derived from autologous blood demonstrate a remarkable 100% healing success rate, providing a revolutionary solution for the management of stubborn and hard-to-heal wounds. By utilizing the body's own regenerative capabilities, this approach ensures highly personalized and effective care, significantly improving patient outcomes
Robust Research Foundation: With a strong scientific foundation supported by over three peer-reviewed publications and 15 patents, the technology showcases innovation and credibility. Its safety and reliability are validated through rigorous testing, including comprehensive immunogenicity assessments and Ames tests, ensuring its biocompatibility and suitability for medical use
Therapeutic Versatility: This cutting-edge technology offers versatile applications, effectively treating conditions such as diabetic foot ulcers, burns, eczema, and dermatitis. In addition, ongoing research highlights its potential in areas like spinal nerve recovery, arthritis treatment, and anti-aging skin therapies, paving the way for significant advancements in healthcare and aesthetics
Inventors
Applicable Industries
Potential Application
Technology Focus
TRL
Images
